NCT06729645NOT_YET_RECRUITINGanonymous

ACO/ARO/AIO-22 - External Beam Radiotherapy Combined With Endorectal High-dose-ratebrachytherapy in Elderly and Frail Patients With Rectal Cancer. A Prospective Multicentre Trial of the German Rectal Cancer Study Group

Sponsor

Source record

University Hospital of Cologne

Phase

Source record

Modality

AI-normalized

RNA therapy

Target

AI-normalized

radiotherapy

Indication / condition

AI-normalized

Rectal Cancer

Intervention

Source record

radiotherapy

Source & freshness

Source record

NCT ID

NCT06729645

Original source

ClinicalTrials.gov

Source last updated

May 01, 2026

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT06729645

Title

ACO/ARO/AIO-22 - External Beam Radiotherapy Combined With Endorectal High-dose-ratebrachytherapy in Elderly and Frail Patients With Rectal Cancer. A Prospective Multicentre Trial of the German Rectal Cancer Study Group

Sponsor

University Hospital of Cologne

Status

NOT_YET_RECRUITING

Phase

Condition raw

Rectal Cancer

Condition normalized

Rectal Cancer

Modality raw

RNA therapy

Modality normalized

RNA therapy

Target raw

radiotherapy

Target normalized

radiotherapy

Interventions

radiotherapy

Public preview

Source record

ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-ratebrachytherapy in elderly and frail patients with rectal cancer.

A prospective multicentre trial of the German Rectal Cancer Study Group.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

ACO/ARO/AIO-22 - External Beam Radiotherapy Combined With Endorectal High-dose-ratebrachytherapy in Elderly and Frail Patients With Rectal Cancer. A Prospective Multicentre Trial of the German Rectal Cancer Study Group

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT06729645

Status

NOT_YET_RECRUITING

Phase

Sponsor

University Hospital of Cologne

Executive brief

Investment-Ready Snapshot

ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-ratebrachytherapy in elderly and frail patients with rectal cancer. A prospective multicentre trial of the German Rectal Cancer Study Group.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedMay 01, 2026

Internal syncJun 11, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT06729645

Indication

Rectal Cancer

Modality

RNA therapy

Target

radiotherapy

Intervention

radiotherapy

Source record